Skip to main content
OpenTrials
Completed

NCT Number: NCT05612425

Text Message Safety Behavior Fading for Appearance Concerns

The current study aims to explore the efficacy of a text message based safety behavior fadinig intervention compared to an unhealthy behavior fading intervention for appearance concerns.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Body Dysmorphic Disorders Anxiety Disorders Eating Disorders Feeding and Eating Disorders Mental Disorders Pathological Conditions, Signs and Symptoms Phobia, Social Phobic Disorders Signs and Symptoms Signs and Symptoms, Digestive Social Anxiety Disorder Somatoform Disorders

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Florida State University, Department of Psychology

Tallahassee, Florida, 32306, United States

About this study

Description: Appearance-related safety behavior fading intervention procedures will follow methodology previously used in the Cougle Lab. The safety behavior fading intervention is designed to target a decrease or elimination of appearance-related safety behaviors.

Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day.

Individuals randomly assigned to the unhealthy behavior fading condition will receive instructions to decrease or eliminate unhealthy behaviors. They will also receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elevated appearance concerns as defined by a score of 53 or higher on the SAAS
  • Being female

Exclusion criteria

  • being male
  • Score of 52 or lower on the SAAS
  • Currently receiving treatment (therapy, counseling, etc.) for anxiety, depression, eating disorder, or body image/appearance concerns
  • If applicable, unstable psychiatric medication usage any time over the past 4 weeks

Treatment and study plan

Safety Behavior Fading for Appearance Concerns

Behavioral

Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.

Unhealthy Behavior Fading

Behavioral

Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.

Primary outcomes

  1. Change in Social Appearance Anxiety Scale

    Time frame: Day 0, Day 28, Day 56

    Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.

  2. Change in Eating Disorder-15

    Time frame: Day 0, Day 28, Day 56

    Self-report scale that measures eating disorder symptoms. Scores range from 0 to 90 with higher scores indicating higher levels of eating pathology.

  3. Change in Social Phobia Inventory

    Time frame: Day 0, Day 28, Day 56

    Self-report scale that measures social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety.

  4. Credibility and Expectancy Questionnaire

    Time frame: Day 0

    Self-report scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies.

  5. Change in Appearance Behaviors Checklist

    Time frame: Day 0, Day 28, Day 56

    Self-report scale used to measure frequency of engaging in appearance related safety behaviors. This scale will be used as a manipulation check.

  6. Change in Unhealthy Behaviors Checklist

    Time frame: Day 0, Day 28, Day 56

    Self-report scale used to measure frequency of engaging in unhealthy behaviors. This scale will be used as a manipulation check.

  7. Beliefs About Appearance Scale

    Time frame: Day 0, Day 28, Day 56

    Self-report scale for measuring appearance importance for use in clinical outcome studies. Each item is rated on a 0-4 scale with a total score range of 0-80 with higher scores indicating greater appearance importance.

  8. UCLA Loneliness Scale-8

    Time frame: Day 0, Day 28, Day 56

    Self-report scale for measuring loneliness for use in clinical outcome studies. Total scores range from 0 to 32 with higher scores indicating higher loneliness.

Secondary outcomes

  1. Center for Epidemiologic Studies Depression Scale

    Time frame: Day 0, Day 28, Day 56

    Self-report measure of depression symptom severity.

  2. Assessment of ideal self

    Time frame: Day 0, Day 28, Day 56

    Self-report measure of appearance importance where individuals must allocate a budget of 100 to 7 different ideals including appearance, creativity, friendliness, work ethic, intelligence, humor, and income.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Registry information

Official study title

Safety Behavior Fading Versus Unhealthy Behavior Fading for Appearance Concerns: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Nov 10, 2022
Registry last updated
May 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.